9 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Request for Proposals: Hematology Oncology Pharmacy Association 2013 Research Award
The HOPA Foundation Board announces the opening of a call for proposals for the 2013 HOPA Foundation Research Award. The HOPA Foundation will fund up to 3 grants based on the stated scope of work. A total of $50,000 in funding is available to be awarded in 2013 through a competitive peer-review process described below.
The individual award is intended to support a hematology/oncology pharmacy practice research project with subsequent publication that aligns with the strategic plan of the HOPA Foundation. Pharmacy practice is broadly defined including areas such as outcomes, surveys, patient safety, standards validation, and translational science applications. Multiple institutions may be involved in the project, and co-PI projects are allowed. The grant is open to all members of HOPA except standing members of the HOPA Foundation and HOPA Board Members.
The HOPA research grants are intended to provide support for projects that are likely to result in facilitating the efforts of hematology/oncology pharmacists to optimize the care of individuals affected by cancer.
The HOPA Foundation Research Grant Review Panel will be chaired by a Foundation Board member; however its composition may vary based on the nature of the proposals received. Members will be comprised of individuals with expertise and familiarity in practice and research.
1. A Letter of Intent (LOI) must be submitted electronically by June 14, 2013 to the attention of Susan Floutsakos at (email@example.com) who will act as the Grant Administrator.
2. The LOIs will be reviewed by members of the HOPA Foundation Research Grant Panel and a decision regarding acceptance for development into a full grant proposal in July 2013. Concepts presented in the LOI that do not address stated objectives and/or criteria of the RFP will be returned and not considered further with a letter of explanation.
3. Submitters of LOIs that are approved for development will be invited to prepare a full grant proposal using the current NIH format. Refer to http://grants.nih.gov/grants/funding/phs398/phs398.html for format. The grant proposals will be due by September 16, 2013. Grant applications must be submitted electronically as a single pdf file to Susan Floutsakos, (firstname.lastname@example.org) the Grant Administrator.
4. The public announcement of the awards will occur in late November 2013. All applicants will receive written feedback regarding review of their application.
1. Funds will be released to the investigator in their entirety, contingent upon Institutional Review Board approval, unless stipulations are placed on the disbursement by the HOPA Foundation Research Panel in its review of the application.
2. The awardee is required to submit a report of progress every six months to the HOPA Foundation Board Chair.
3. The awardee is expected to present the results of their research at the HOPA annual meeting. This presentation is expected to occur no later than two years after the release of the research funds. The results of the study are expected to be submitted for publication in a peer-reviewed biomedical print or online journal. The HOPA Foundation is to be acknowledged in any presentation or publication for its support of the research.
4. There is no provision for indirect costs in this research grant. A travel budget is expected to be included in the proposal to allow the presentation of the results at the HOPA annual meeting. Additional travel funds should be justified in the context of the needs of the project. Capital equipment purchases are not allowed in this grant.
5. All unused funds remaining from the grant 24 months after the disbursement must be returned to HOPA. The investigator may petition the HOPA Foundation for an extension for use of the funds. This request for an extension must be made at least six months before the expiration of the grant.
Call for Nominations: Rawls-Palmer Progress in Medicine Award
The Rawls-Palmer Progress in Medicine Award was established in 1978 by Dr. W. B. Rawls to further his commitment to continuing medical education and its impact on patient care. This award was founded through the generosity of the late Dr. and Mrs. W.B. Rawls, and honors the memory of their parents.
The goal of the Rawls-Palmer Progress in Medicine Award is to incorporate the efforts of modern research in patient care and to help bridge the gap between the results of research and its application in patient care.
The candidate must be an investigator who is actively involved in high-quality clinical pharmacologic research and capable of delivering an engaging, comprehensive lecture on recent developments in clinical pharmacology and therapeutics.
Prize and Presentation
The Rawls-Palmer Progress in Medicine Award is presented at the ASCPT Annual Meeting. The recipient will present a lecture focusing on recent developments in clinical pharmacology. In addition, the recipient will receive a $1,000 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
The nomination deadline is Thursday, June 27, 2013.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at email@example.com.
Call for Nominations: William B. Abrams Award in Geriatric Clinical Pharmacology
The William B. Abrams Award in Geriatric Clinical Pharmacology was established with support from the Merck Company Foundation in 1996 to honor an investigator in geriatric clinical pharmacology for outstanding contributions to the field.
Dr. Abrams, a Past President of ASCPT, had a long and illustrious career in the pharmaceutical industry, mostly at the Merck Research Laboratories. Among his many accomplishments in geriatric clinical pharmacology, he was the founding Co-Editor of the Merck Manual of Geriatrics, created the Scientific Section on Geriatric Clinical Pharmacology of ASCPT, and developed and funded post-doctoral training programs in geriatric clinical pharmacology.
Dr. Abrams' objective in establishing this award was to encourage more young scientists to enter the field of geriatric clinical pharmacology by recognizing accomplishments in the field at the Society's Annual Meeting.
This award is funded on behalf of Dr. Abrams through the generosity of The Merck Company Foundation.
A nominee must be an investigator in geriatrics who is actively involved in high-quality teaching and research in geriatric clinical pharmacology.
Prize and Presentation
The William B. Abrams Award in Geriatric Clinical Pharmacology is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Henry W. Elliott Distinguished Service Award
The Henry W. Elliott Distinguished Service Award was established in 1979 to recognize an ASCPT member who has gone above and beyond the call of duty in service to the organization.
The goal of the Henry W. Elliott Distinguished Service Award is to acknowledge outstanding efforts on behalf of the organization by an individual member and in doing so, encourage other ASCPT members to contribute their time and talent to the Society.
A nominee must be a member of ASCPT and cannot have held the position of President-Elect or President of the Society within the last five years. The essential criterion documented evidence of excellent service to the organization. One or two outstanding acts of service or a long record of many acts of service may justify the award. The recipient should have a record of continuous service to the Society, including one or many major accomplishments.
The Henry W. Elliott Distinguished Service Award is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Sheiner-Beal Pharmacometrics Award
The Sheiner-Beal Pharmacometrics Award has been established as an ASCPT Award by the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) to acknowledge the pioneering contributions of Drs. Lewis B. Sheiner and Stuart Beal to the scientific discipline of pharmacometrics.
Pharmacometrics is defined as the science that quantifies drug, disease and clinical trial information to aid efficient drug development, regulatory decisions and rational therapeutic decision making in patients. It uses models that are generally based on pharmacology, physiology, genetic constitution and/or disease for quantitative analysis of interactions between drugs and patients. The domain of pharmacometrics includes the application of techniques that address the interactions between pharmacokinetics, pharmacodynamics, pharmacogenomics, and disease progression with a focus on populations and variability in the exposure-response relationship.
The goal of the Sheiner-Beal Pharmacometrics Award is to recognize outstanding achievements at the forefront of research or leadership in pharmacometrics and/or application of pharmacometric concepts and techniques to enhance research, development, regulatory evaluation, and/or utilization of therapeutic products.
The candidate must be an investigator or leader who is actively advancing the scientific discipline of pharmacometrics and/or its impact on research, development, regulatory evaluation, or utilization of therapeutic products, and is capable of delivering an engaging and comprehensive lecture on pharmacometrics. The award is intended to recognize clinical pharmacologists, clinician scientists, computational scientists, statisticians and others in academia, industry, government agencies, or consulting whose work falls within the scope of the definition of pharmacometrics.
The Sheiner-Beal Pharmacometrics Award will be presented annually at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient will receive a $1,500 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Leon I. Goldberg Young Investigator Award
The Leon I. Goldberg Young Investigator Award was established in 1986 to honor a young scientist for accomplishments in the field of clinical pharmacology achieved early in his/her career.
The goal of the Leon I. Goldberg Young Investigator Award is to encourage and recognize young scientists active in the field of clinical pharmacology.
There are no restrictions concerning the scientific field in which nominees have earned their doctoral degrees. Nominees must be no more than 45 years of age as of March 1 of the year in which the award is presented. Although it is encouraged, a nominee need not be a member of the Society.
The Leon I. Goldberg Young Investigator Award is presented at the ASCPT Annual Meeting. The recipient will deliver a lecture on his/her work. In addition, the recipient of the award will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration are reimbursed by the Society.
Call for Nominations: Gary Neil Prize for Innovation in Drug Development
The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several other biotech companies.
The goal of the Gary Neil Prize for Innovation in Drug Development is to stimulate the application of innovative science to clinical drug development by recognizing outstanding individuals or teams who have been leaders in this area.
Individuals as well as teams who have demonstrated leadership in the application of significant, innovative science to clinical drug development. The award is open to individuals from all clinical pharmacology employment sectors.
The Gary Neil Prize for Innovation in Drug Development will be presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $2,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at firstname.lastname@example.org
Call for Nominations: Oscar B. Hunter Memorial Award in Therapeutics
The Oscar B. Hunter Memorial Award in Therapeutics was established in 1955 to honor individual scientists for outstanding contributions to clinical pharmacology and therapeutics. This award recognizes a meritorious career in drug research, excellence or contributions in direct patient care, and a distinguished teaching career.
The Oscar B. Hunter Memorial Award in Therapeutics is the Society's premier award. The goal of the award is to honor a scientist for outstanding contributions to clinical pharmacology and therapeutics over the individual's professional life.
A nominee must be able to provide evidence of an exemplary career in drug research, significant contributions to excellence in patient care, and a distinguished teaching career.
The Oscar B. Hunter Memorial Award in Therapeutics is presented at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient of the award will receive a bronze medal mounted on a plaque and a $1,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Request for Proposals: Society of Infectious Diseases Pharmacists Infectious Diseases Pharmacotherapy Young Investigator Research Award
SIDP is soliciting ID pharmacotherapy research proposals from SIDP members who qualify as young investigators.
The primary purpose of the research award is to provide funding for research projects that will contribute to the further development of the principal investigator’s research career and improve their competitiveness for future extramural funding. Favorable consideration will be given to research proposals which focus on current pharmacotherapy issues surrounding the prevention and management of infectious diseases. Applications must be submitted no later than 5PM E.S.T on Friday, August 9, 2013.
Funding: Financial support for individual proposals is limited to $10,000.